Drugs with verified catalysts

584 drugs/products referenced in verified catalyst events. Verified as of 2026-08-06.

DrugCatalysts
KarXT5
ROSUVASTATIN CALCIUM4
TPSAC4
Ruxolitinib Cream, Vehicle Cream3
Nemolizumab3
Tirzepatide3
Litifilimab3
Leniolisib3
Deucravacitinib3
Bimekizumab2
Briquilimab2
Fitusiran2
Dazodalibep2
LP3522
Satralizumab2
KHK4951, Aflibercept Injection2
AMDX-2011P2
Neflamapimod2
Lu AG139092
TAK-2792
Sonrotoclax, Zanubrutinib2
Efgartigimod PH20 SC2
Ziltivekimab2
BHV-7000, BHV-70002
barzolvolimab, Matching placebo2
Apalutamide, Androgen-deprivation Therapy (ADT)2
Itepekimab (SAR440340), Mometasone furoate nasal spray (MFNS)2
Povorcitinib2
Cenerimod2
FBX-1012
IMU-838 tablets2
Tobevibart, Elebsiran, Bulevirtide2
Investigational varicella vaccine, Marketed varicella vaccine, Measles, mumps, and rubella vaccine, Hepatitis A vaccine2
TAK-3602
Kedrion IVIG 10%2
RLS-00712
Ebselen2
Solriamfetol 150 mg, Solriamfetol 300 mg2
ENV-2942
Corabotase2
SAR4429702
FDORA2
COVID2
Apremilast1
Efinopegdutide1
Yellow fever vaccine (live), Yellow fever vaccine (live), Yellow fever vaccine (live), Measles, combinations with mumps and rubella, live attenuated1
rozanolixizumab1
Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab1
Enlicitide, Rosuvastatin1
Petrelintide1
Boric acid1
Nexium 20mg, Nexium 10mg1
Amnio-Maxx® Dual Layer Amnion Patch1
rezatapopt, pembrolizumab1
exidavnemab1
Ensifentrine 3 mg, Glycopyrrolate 21.25 mcg, Glycopyrrolate 42.5 mcg1
Raludotatug Deruxtecan (R-DXd)1
CAB LA + RPV LA, Oral ART1
Vicadrostat, Empagliflozin1
Avelumab1
Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan, Lenvatinib1
Pembrolizumab, MK-4830, Belzutifan, Lenvatinib1
CagriSema (Cagrilintide B and Semaglutide I)1
NT-07961
PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation1
AZD9833, Anastrozole, Anastrozole placebo, AZD9833 placebo1
Danicopan1
RO7204239, RO7204239 Matching Placebo, Tirzepatide1
BPM31510, Vitamin K1, Temozolomide (TMZ), Radiation1
JDQ443, docetaxel1
Rilzabrutinib dose 1, Rilzabrutinib dose 21
Lutetium (177Lu) rhPSMA-10.1 Injection, 18F-rhPSMA-7.3 injection (in phase 1 only)1
teplizumab1
AZD29361
Giredestrant1
Alectinib, Cisplatin, Carboplatin, Pemetrexed1
4P0041
SBP-101, Nab-paclitaxel, Gemcitabine1
PTX-9908 Injection1
ONC-392, Pembrolizumab1
Elranatamab, Elotuzumab, Pomalidomide, Dexamethasone1
RCT2100, RCT2100, RCT2100, Ivacaftor1
NPT 20421
Ferumoxytol, Iron sucrose1
zolbetuximab, nab-paclitaxel, gemcitabine1
Trastuzumab deruxtecan, Ramucirumab, Paclitaxel1
rAAV-Olig001-ASPA, Levetiracetam, Prednisone1
Staccato alprazolam1
LMN-2011
TS231
avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel1
Sefaxersen (RO7434656)1
NBQ72S1
HS-20093, Gemcitabine combined with docetaxel1
RSVpreF1
Filgotinib1
TAF1
AMDC-USR (iltamiocel)1
Selinexor, Physician's Choice Treatment1
Newnorm1
Tasimelteon1
Qudexy XR1
Tafasitamab, Lenalidomide, Rituximab, Cyclophosphamide1
64Cu-SAR-bisPSMA, 67Cu-SAR-bisPSMA1
Sacituzumab Govitecan-hziy (SG), Pembrolizumab, Carboplatin, Cisplatin1
Sevasemten 10 mg, Sevasemten 5 mg, Sevasemten 12.5 mg1
OLZ/SAM, Olanzapine1
ORIC-114, Chemotherapy drug1
SLN1241
ARV-471, Abemaciclib1
Tenapanor 50 MG, Tenapanor 25 mg bid1
Drug: Normal Saline, Sovateltide1
RGX-2021
RiMO-3011
DPI-386 Nasal Gel, Other (e.g., promethazine, meclizine)1
TNG260, Pembrolizumab1
GIM1221
64Cu-SAR-bisPSMA1
Dostarlimab, Belrestotug, Nelistotug, Remzistotug1
Piflufolastat F 18 Intravenous Solution [PYLARIFY]1
TOUR006 - 20 MG, TOUR006 - 50 MG1
Adalimumab, Risankizumab1
Miricorilant (Cohort A), Miricorilant (Cohort B)1
fenfluramine1
Axatilimab1
Copper Cu 64 PSMA I&T1
Foralumab1
LY3650150, Standard therapy for INCS1
WVE-0061
PCS6422 and capecitabine, Capecitabine1
NNC0519-0130, Semaglutide1
Empasiprubart, IVIG (Intravenous Immunoglobulin), Empasiprubart-placebo, IVIg-placebo1
CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg)1
MZE8291
AR882 50 mg, AR882 75 mg1
Bemnifosbuvir-Ruzasvir (BEM/RZR), Sofosbuvir-Velpatasvir (SOF/VEL)1
DISC-14591
Agitated Saline SoC, ASI-021
Obicetrapib 10mg1
Atacicept1
DT-1681
RAP-2191
Trichostatin A1
CST-30561
VSJ-1101
Nenocorilant 200 mg, Nenocorilant 300 mg, Nenocorilant 400 mg, Nivolumab1
Taldefgrobep Alfa, Taldefgrobep Alfa1
QLS-111 Ophthalmic Solution (0.015%), QLS-111 Ophthalmic Solution (0.075%)1
Aleniglipron1
GLK-321 low dose BID, GLK-321 mid dose BID, GLK-321 high dose BID, GLK-321 high dose QD1
PF-078684891
zongertinib, pembrolizumab, cisplatin, carboplatin1
Methamphetamine, Sterile Saline, CS-11031
Eptinezumab1
BMS-986490, Bevacizumab1
Tulisokibart, Methotrexate1
NDV-HXP-S-KP.2, COVID-19 mRNA Vaccine1
CAB LA, New formulation of CAB LA1
Candidate varicella vaccine, Marketed varicella vaccine, MMR vaccine, Hepatitis A vaccine1
NS-089/NCNP-021
Brepocitinib PO QD1
BAY2599023 (DTX201)1
Pembrolizumab, Carboplatin, Paclitaxel, Docetaxel1
TEV-534081
MET233 and MET097, MET0971
Biological/Vaccine1
Topotecan - usual, Topotecan - study1
Fp/ABS, FP, ABS1
CardiolRx1
T3011, T3011 + pembrolizumab1
Belzutifan, Palbociclib1
mRNA-1403, mRNA-14051
PF-07220060, Letrozole, Fulvestrant, Midazolam1
YTB3231
INCB0992801
AT021
OCU410ST1
Sonelokimab1
Depemokimab, Mepolizumab1
Amlitelimab1
NaBen®1
BI-1206, Rituximab, Acalabrutinib1
Oral repotrectinib (TPX-0005)1
Linerixibat1
BCV1
Glofitamab, Tocilizumab, Doxorubicin, Vincristine1
Durvalumab, Oleclumab, Monalizumab1
JDQ443, trametinib, Ribociclib, cetuximab1
JIN-A021
Adagrasib oral dose of 400 mg twice daily tablets, Pembrolizumab, Chemotherapy: Pemetrexed, Cisplatin/Carboplatin1
OM-851
M1774, Cemiplimab1
BMS-986449, Nivolumab1
Azeliragon1
GSK45272261
AMT-1621
SP-002, Vismodegib1
Ifinatamab deruxtecan, Atezolizumab, Carboplatin1
Dato-DXd, Osimertinib, Pemetrexed, Carboplatin1
HS-20093, Topotecan1
RSVPreF3 OA vaccine1
Ranibizumab, EYE1031
GLM101 (Part A, Double-blind), GLM101 (Part B, Open-label)1
ARO-DIMERPA1
DSP107 + Atezolizumab, Fruquintinib1
sodium monofluorophosphate toothpaste1
Sernova Cell Pouch1
Baricitinib, Tocilizumab1
IV ICT011
Brenetafusp, Brenetafusp and pembrolizumab, Brenetafusp and chemotherapy, Brenetafusp and monoclonal antibodies and chemotherapy1
VV1, Cemiplimab1
LAM5611
Pirtobrutinib, Venetoclax, Rituximab1
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)1
tapinarof cream, 1%1
Iptacopan (LNP023)1
Dazucorilant 300 mg, Dazucorilant 150 mg, Dazucorilant1
ABBV-RGX-314 Dose 1, ABBV-RGX-314 Dose 2, Aflibercept (EYLEA®)1
STAR06021
Afamitresgene autoleucel1
XEN11011
GEn-11241
atumelnant1
PRV211 (Intraoperative Cisplatin System), PRV111 (Cisplatin Transmucosal System), PRV131 (Cisplatin Intratumoral Injectable)1
Rhu-pGSN, normal saline1
YL201 for Injection1
Xanamem1
Debio 43261
Retatrutide1
sabirnetug1
ENV-1011
Maralixibat1
EYP-1901, Aflibercept (2.0 mg)1
ALD-102 Solution1
Vonoprazan1
IMVT-14021
iloperidone1
N-803 (IL-15 Superagonist)1
NVD003, Iliac Crest Bone Graft1
NT 201, NT 201 Placebo1
RTN-001, Matching placebo control1
TRIV-5091
KYN-5356 low dose, KYN-5356 Medium Dose, KYN-5356 High Dose1
CDI-988, Snow Mountain Virus1
Tacrolimus ophthalmic solution1
DISC-09741
HP-2111
Preservative Free Polyethylene glycol 400 0.25%, Propylene Glycol (0.6%), Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%1
TAK-8611
Pacritinib, Physician's Choice medications1
mRNA-11891
BMS-986278, BMS-986278 Placebo1
Dupilumab1
HDM1002 200 mg, HDM1002 400 mg1
Ravulizumab, Pozelimab, Cemdisiran, Eculizumab1
CC-92480, Tazemetostat, BMS-986158, Trametinib1
AAV9 BBP-8121
DWN120881
Cobolimab, Dostarlimab1
SGT-0011
Oregovomab, Paclitaxel, Carboplatin1
AAA617, ARPI: Abiraterone, ARPI: Enzalutamide1
ECC4703, Semaglutide1
AZD6489, Licensed RSV vaccine #1, Licensed RSV vaccine #21
Glofitamab, Atezolizumab, Obinutuzumab, Tocilizumab1
Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes, China Import (dapagliflozin) + China Import (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes1
Benralizumab1
PF-07275315, PF-072646601
DS-3939a1
Tralokinumab + TCS1
Faricimab1
SEP-3638561
Ocrelizumab1
Durvalumab, Tremelimumab, Pemetrexed, Pembrolizumab1
Inclisiran sodium 300 mg1
Volrustomig, Bevacizumab, Lenvatinib, Rilvegostomig1
RO7204239, Risdiplam1
Belzutifan, Pembrolizumab1
BI 771716, Pegcetacoplan1
Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab, Lenvatinib1
Ianalumab, Corticosteroids1
venglustat (GZ402671), imiglucerase1
GAd-209-FSP low dose, MVA-209-FSP low dose, GAd-209-FSP high dose, MVA-209-FSP high dose1
Afuresertib, Afuresertib/placebo1
VX-121/TEZ/D-IVA1
TSN1611, TSN1611, TSN1611, TSN16111
AS1986NS1
18F-metaFluorobenzylguanidine, Rubidium-821
18F-MFBG1
TAK-7881
Alectinib, Atezolizumab, Pemetrexed, Cisplatin1
Eteplirsen1
TAK-788, Pemetrexed, Cisplatin, Carboplatin1
ADG126, Pembrolizumab (KEYTRUDA®)1
AB-10021
Milvexian, Apixaban, Apixaban Placebo1
Tobemstomig, Tiragolumab, Pembrolizumab, Axitinib1
Tobemstomig, Pembrolizumab, Nab-Paclitaxel1
TEV-56248, Albuterol sulfate1
JK071
Vonaprument1
Venetoclax, cBTKi Monotherapy1
anvumetostat1
Setmelanotide1
SPY002-0721
MT-1251
Ublituximab, Ublituximab1
Tuspetinib, Venetoclax Oral Tablet, Azacitidine for Intravenous Infusion1
RO7198457 intravenous (IV), Observational group (no intervention)1
Pyridoxal Phosphate1
BBP-4181
ERAS-007, ERAS-6011
Venetoclax, Obinutuzumab1
Sonrotoclax, Dexamethasone, Carfilzomib, Daratumumab1
BGB-166731
CAM2029, Octreotide LAR, Lanreotide ATG1
Clemizole HCl1
Xcopri1
Obicetrapib1
Mirvetuximab soravtansine, Carboplatin1
ABT-1011
TYRA-3001
Elacestrant1
(Z)-endoxifen, goserelin1
Apitegromab1
Budigalimab, Livmoniplimab, Lenvatinib, Sorafenib1
Onvansertib, FOLFIRI, Bevacizumab, FOLFOX1
YL202 should be intravenously infused1
Cretostimogene Grenadenorepvec, n-dodecyl-B-D-maltoside1
XTMAB-161
Empasiprubart IV1
FNP-2231
APG7771
obicetrapib 10 mg + obicetrapib/evolocumab 140 mg Q 2 weeks1
CRB-601 monoclonal antibody, Anti-PD-1 monoclonal antibody1
Orforglipron1
Retatrutide, Tirzepatide1
CAL1011
Tirbanibulin ointment 1%1
ALKS 26801
ABBV-932, Antidepressant Therapy (ADT)1
CYB704, Ocrevus-EU, Ocrevus-US1
Tibulizumab Dose A, Tibulizumab Dose B1
RE104 for Injection1
DBV712 250 mcg1
AR882 75 mg, XOI Low Dose, XOI High Dose1
LY3938577, Degludec1
LY45151001
Colgate SNaP Total 10/10, 1.5 Taurate, Colgate Great Regular Flavor Toothpaste, Flat Trimmed Extra Clean TB1
Dostarlimab1
Anifrolumab1
cemiplimab, Fixed Dose Combination (FDC) cemiplimab+fianlimab1
LOU064 (blinded)1
dabrafenib, trametinib1
Parsaclisib, parsaclisib + itacitinib, parsaclisib + ruxolitinib, parsaclisib + ibrutinib1
pembrolizumab, doxorubicin, vinblastine, dacarbazine1
Pembrolizumab, Dostarlimab, Belrestotug, Nelistotug1
Trastuzumab deruxtecan, Taxane, Pertuzumab, Trastuzumab1
Milvexian1
PRGN-2009 plus Pembrolizumab1
REGN7075, Cemiplimab, Platinum-based doublet chemotherapy, Bevacizumab1
Inavolisib, Fulvestrant, Alpelisib, Bupropion1
AZD04861
Olatorepatide1
Metaxalone 640 mg Oral Tablet1
PA5108 Ocular Implant low dose, PA5108 Ocular Implant, high dose, Latanoprost 0.005% Ophthalmic Solution1
Zilucoplan1
Tulisokibart1
AZD0901, 5-Fluorouracil, Leucovorin, l-leucovorin1
Efanesoctocog alfa1
ETOPOSIDE - Usual, ETOPOSIDE - Study1
Abiraterone - Usual, Abiraterone - Study1
Alectinib - Usual, Alectinib - Study1
SMS0011
NVX-CoV27051
BE1116, FFP1
RO72691621
JNJ-955975281
povorcitinib, ICS-LABA1
Nimacimab injection, Nimacimab placebo injection, semaglutide injection, Nimacimab 300 mg injection1
Dostarlimab, CAPEOX1
AZD0754, AZD22871
TX000045- Dose A, TX000045- Dose B1
Dostarlimab, Carboplatin, Paclitaxel, Niraparib1
RO7795081, Semaglutide1
TB0061
Rimegepant, Rimegepant1
CC-92480, Bortezomib, Dexamethasone, Daratumumab1
Alectinib, Entrectinib, Vemurafenib, Cobimetinib1
Anvumetostat, Docetaxel, Comparator Anvumetostat Test Tablet1
mRNA-37451
AVTX-803 (L-Fucose)1
ONC-392 low, ONC-392 high, lutetium Lu 177 vipivotide tetraxetan1
Adagrasib1
AAV9-hSyn1-miGRIK21
AU-011, SCS Microinjector, Laser1
Decartes-081
D-0502, Fulvestrant1
Jynneos, MVA-BN (Quail)1
rilzabrutinib1
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.